Chemoinformaics analysis of 2-Nitro-1,5-P-Menthadiene
| Molecular Weight | 181.235 | nRot | 2 |
| Heavy Atom Molecular Weight | 166.115 | nRig | 7 |
| Exact Molecular Weight | 181.11 | nRing | 1 |
| Solubility: LogS | -3.365 | nHRing | 0 |
| Solubility: LogP | 3.074 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 29.4059 |
| nHD | 0 | BPOL | 16.2141 |
| QED | 0.485 |
| Synth | 3.884 |
| Natural Product Likeliness | 0.861 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.338 |
| MDCK | 0.000178434 |
| BBB | 0.911 |
| PPB | 0.905134 |
| VDSS | 1.037 |
| FU | 0.0699104 |
| CYP1A2-inh | 0.297 |
| CYP1A2-sub | 0.511 |
| CYP2c19-inh | 0.682 |
| CYP2c19-sub | 0.85 |
| CYP2c9-inh | 0.389 |
| CYP2c9-sub | 0.212 |
| CYP2d6-inh | 0.055 |
| CYP2d6-sub | 0.415 |
| CYP3a4-inh | 0.226 |
| CYP3a4-sub | 0.656 |
| CL | 8.525 |
| T12 | 0.66 |
| hERG | 0.028 |
| Ames | 0.185 |
| ROA | 0.126 |
| SkinSen | 0.942 |
| Carcinogencity | 0.94 |
| EI | 0.762 |
| Respiratory | 0.958 |
| NR-Aromatase | 0.036 |
| Antiviral | No |
| Prediction | 0.922743 |